CalciMedica CALC
NASDAQ CALC
$1.41 -0.11 (-7.27%)
As of: Nov 10, 2026 · 12:58 PM EST

CalciMedica (CALC) EBITDA Margin (2024)

Updated

CalciMedica's EBITDA Margin came in at -2877.57% for Q4 2024, down 252.80 percentage points from the prior quarter.

Analysis

CalciMedica (CALC) EBITDA Margin (2024) Analysis & Trends

For FY2024, CalciMedica's EBITDA Margin was -2381.26%.

  • Business Quant data shows CALC's EBITDA Margin at -2624.77% (Q3 2024), -2368.73% (Q2 2024) and -1873.62% (Q1 2024) in the three quarters before Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 54.65%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 32.68%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 46.88%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 40.75%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 46.62%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 50.63%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 42.49%
10 CalciMedica 5.20 Mn -13.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -2,877.57%
Sep 30, 2024 -2,624.77%
Jun 30, 2024 -2,368.73%
Mar 31, 2024 -1,873.62%
API Access

CalciMedica EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CALC&period=max&api_key=YOUR_API_KEY